Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Scraping By: The Pro-Buyer "Materiality Scrape" Provision Finds a Foothold in Private M&A Negotiations

Related Content

The Delaware Question

Why the AI Race Hinges on Elite Talent

ISS Announces Benchmark Policy Update for 2026

How to Secure and Retain Top Talent in Asset Purchases

SEC’s Division of Corporation Finance Provides Post-Shutdown Guidance

California Air Resources Board Posts Draft Scope 1 and 2 GHG Reporting Template

SEC Chairman Vows to Make IPOs Great Again

M&A Activity Continues to Escalate in the Global Hotel Operator Sector

Goodwin Represents Cycle Pharmaceuticals in Acquisition of Applied Therapeutics

Goodwin Highly Ranked in IFLR1000’s 2026 Financial and Corporate Law Rankings

Goodwin Advises Lumine Group on Agreement to Acquire Synchronoss Technologies

Goodwin Expands London Technology M&A Team with the Arrival of Emmie Jones

The Wolves Are Howling: Activist Packs Are Complicating Engagement (Agenda)

Goodwin Advises Avadel Pharmaceuticals on Increased Offer from Alkermes

Goodwin Advises Centerview Partners on Semrush’s $1.9 Billion Acquisition by Adobe

Goodwin Advises SixPeaks Bio on Acquisition by AstraZeneca for Up to $300 Million

Technology

Private Equity

Mergers & Acquisitions

Capital Markets